Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related macular degeneration

V. Blaha, JU. Rathouska, H. Langrova, M. Blaha, J. Studnicka, C. Andrys, V. Loefflerova, M. Lanska, E. Vejrazkova, P. Nachtigal, A. Stepanov

. 2024 ; 14 (1) : 28902. [pub] 20241121

Language English Country England, Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc25003416

Grant support
17-29241A Ministerstvo Zdravotnictví Ceské Republiky
CZ.02.01.01/00/22_008/0004607 European Union

Age-related macular degeneration (AMD) is a progressive chronic disease causing visual impairment or central vision loss in the elderly. We hypothesized that successful rheopheresis would be associated with positive changes in soluble endoglin (sENG), PSCK9, alpha-2-macroglobulin (A2M), and hs-CRP levels. 31 elderly patients with the dry form of AMD, treated with rheopheresis with a follow-up period of at least 5 years and an average age of 68 ± 4 years, were evaluated. Each treated patient received a series of 8 procedures in 10 weeks and, after the 2-year period, another 2 procedures within 1 week. Then, the patients were followed up every 6 months and divided into the successfully treated and therapeutic failure group according to best-corrected visual acuity (BCVA), size of the drusen area, and the drusenoid pigment epithelium detachment (DPED). Based on the ophthalmological assessment, rheopheresis treatment was successful in 73% of AMD patients. The therapy was associated with a significant decrease in total cholesterol, LDL-C, HDL-C, apoprotein B, lipoprotein (a) levels, and rheologically important parameters, irrespective of the therapy's success or failure. The success of rheopheresis therapy was exclusively related to a significant decrease in sENG and A2M levels. Over the long term, rheopheresis prevented the decline of BCVA, reduced the DPED and area of macular drusen, and improved the preservation of an intact photoreceptor ellipsoid zone in most patients. Moreover, we showed for the first time that sENG and A2M could be potentially sensitive biomarkers of successful rheopheresis procedure, irrespective of lipid parameters changes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003416
003      
CZ-PrNML
005      
20250206104330.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-024-80375-5 $2 doi
035    __
$a (PubMed)39572693
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Blaha, Vladimir $u Faculty of Medicine in Hradec Kralove, 3rd Department of Internal Medicine - Metabolism and Gerontology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic
245    10
$a Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related macular degeneration / $c V. Blaha, JU. Rathouska, H. Langrova, M. Blaha, J. Studnicka, C. Andrys, V. Loefflerova, M. Lanska, E. Vejrazkova, P. Nachtigal, A. Stepanov
520    9_
$a Age-related macular degeneration (AMD) is a progressive chronic disease causing visual impairment or central vision loss in the elderly. We hypothesized that successful rheopheresis would be associated with positive changes in soluble endoglin (sENG), PSCK9, alpha-2-macroglobulin (A2M), and hs-CRP levels. 31 elderly patients with the dry form of AMD, treated with rheopheresis with a follow-up period of at least 5 years and an average age of 68 ± 4 years, were evaluated. Each treated patient received a series of 8 procedures in 10 weeks and, after the 2-year period, another 2 procedures within 1 week. Then, the patients were followed up every 6 months and divided into the successfully treated and therapeutic failure group according to best-corrected visual acuity (BCVA), size of the drusen area, and the drusenoid pigment epithelium detachment (DPED). Based on the ophthalmological assessment, rheopheresis treatment was successful in 73% of AMD patients. The therapy was associated with a significant decrease in total cholesterol, LDL-C, HDL-C, apoprotein B, lipoprotein (a) levels, and rheologically important parameters, irrespective of the therapy's success or failure. The success of rheopheresis therapy was exclusively related to a significant decrease in sENG and A2M levels. Over the long term, rheopheresis prevented the decline of BCVA, reduced the DPED and area of macular drusen, and improved the preservation of an intact photoreceptor ellipsoid zone in most patients. Moreover, we showed for the first time that sENG and A2M could be potentially sensitive biomarkers of successful rheopheresis procedure, irrespective of lipid parameters changes.
650    _2
$a lidé $7 D006801
650    _2
$a senioři $7 D000368
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a biologické markery $x krev $7 D015415
650    12
$a makulární degenerace $x terapie $x krev $7 D008268
650    12
$a endoglin $x krev $7 D000071063
650    _2
$a výsledek terapie $7 D016896
650    _2
$a lidé středního věku $7 D008875
650    _2
$a zraková ostrost $7 D014792
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rathouska, Jana Urbankova $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Heyrovskeho 1203, 500 05, Hradec Kralove, Czech Republic
700    1_
$a Langrova, Hana $u Faculty of Medicine in Hradec Kralove, Department of Ophthalmology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic
700    1_
$a Blaha, Milan $u Faculty of Medicine in Hradec Kralove, 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic
700    1_
$a Studnicka, Jan $u Faculty of Medicine in Hradec Kralove, Department of Ophthalmology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic
700    1_
$a Andrys, Ctirad $u Department of Immunology and Allergology, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic
700    1_
$a Loefflerova, Veronika $u Department of Ophthalmology, Regional Hospital Liberec, Liberec, Czech Republic
700    1_
$a Lanska, Miriam $u Faculty of Medicine in Hradec Kralove, 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic
700    1_
$a Vejrazkova, Eva $u Faculty of Medicine in Hradec Kralove, 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic
700    1_
$a Nachtigal, Petr $u Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University, Heyrovskeho 1203, 500 05, Hradec Kralove, Czech Republic. petr.nachtigal@faf.cuni.cz
700    1_
$a Stepanov, Alexandr $u Faculty of Medicine in Hradec Kralove, Department of Ophthalmology, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 14, č. 1 (2024), s. 28902
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39572693 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104325 $b ABA008
999    __
$a ok $b bmc $g 2263286 $s 1239423
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 14 $c 1 $d 28902 $e 20241121 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
GRA    __
$a 17-29241A $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a CZ.02.01.01/00/22_008/0004607 $p European Union
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Archiving options